Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials

J Antimicrob Chemother. 2018 Jun 1;73(6):1728-1730. doi: 10.1093/jac/dky086.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / therapeutic use
  • Cohort Studies
  • Cross-Sectional Studies
  • Darunavir / administration & dosage*
  • Darunavir / therapeutic use
  • Drug Dosage Calculations*
  • Equivalence Trials as Topic*
  • Female
  • HIV Infections / drug therapy*
  • HIV-1 / drug effects
  • Humans
  • Male
  • Middle Aged
  • Ritonavir / administration & dosage*
  • Ritonavir / therapeutic use

Substances

  • Anti-HIV Agents
  • Ritonavir
  • Darunavir